Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 23226014)

1.

The burden of chronic obstructive pulmonary disease among employed adults.

DiBonaventura Md, Paulose-Ram R, Su J, McDonald M, Zou KH, Wagner JS, Shah H.

Int J Chron Obstruct Pulmon Dis. 2012;7:211-9. doi: 10.2147/COPD.S29280. Epub 2012 Mar 19.

2.

The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce.

DiBonaventura Md, Paulose-Ram R, Su J, McDonald M, Zou KH, Wagner JS, Shah H.

COPD. 2012 Feb;9(1):46-57. doi: 10.3109/15412555.2011.634863.

PMID:
22292597
3.

The clinical features of the overlap between COPD and asthma.

Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, Crapo JD, Hersh CP; COPDGene Investigators.

Respir Res. 2011 Sep 27;12:127. doi: 10.1186/1465-9921-12-127.

4.

Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes.

Finkelstein EA, Allaire BT, DiBonaventura MD, Burgess SM.

J Occup Environ Med. 2011 Sep;53(9):1025-9. doi: 10.1097/JOM.0b013e318229aae4.

PMID:
21866052
5.

Current controversies and future perspectives in chronic obstructive pulmonary disease.

Agustí A, Vestbo J.

Am J Respir Crit Care Med. 2011 Sep 1;184(5):507-13. doi: 10.1164/rccm.201103-0405PP. Review.

PMID:
21680951
6.

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators.

N Engl J Med. 2011 Mar 24;364(12):1093-1103. doi: 10.1056/NEJMoa1008378.

7.

The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities.

DiBonaventura Md, Wagner JS, Yuan Y, L'Italien G, Langley P, Ray Kim W.

J Med Econ. 2011;14(2):253-61. doi: 10.3111/13696998.2011.566294. Epub 2011 Mar 9.

PMID:
21385147
8.

Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data.

Mapel DW, Dutro MP, Marton JP, Woodruff K, Make B.

BMC Health Serv Res. 2011 Feb 23;11:43. doi: 10.1186/1472-6963-11-43.

9.

COPD, chronic bronchitis and capacity for day-to-day activities: negative impact of illness on the health-related quality of life.

Kanervisto M, Saarelainen S, Vasankari T, Jousilahti P, Heistaro S, Heliövaara M, Luukkaala T, Paavilainen E.

Chron Respir Dis. 2010;7(4):207-15. doi: 10.1177/1479972310368691.

PMID:
21084545
10.

Misdiagnosis of patients receiving inhaled therapies in primary care.

Izquierdo JL, Martín A, de Lucas P, Rodríguez-González-Moro JM, Almonacid C, Paravisini A.

Int J Chron Obstruct Pulmon Dis. 2010 Aug 9;5:241-9.

11.

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ.

Am J Respir Crit Care Med. 2010 Sep 1;182(5):598-604. doi: 10.1164/rccm.200912-1843CC. Epub 2010 Jun 3.

PMID:
20522794
12.

Chronic obstructive pulmonary disease in non-smokers.

Salvi SS, Barnes PJ.

Lancet. 2009 Aug 29;374(9691):733-43. doi: 10.1016/S0140-6736(09)61303-9. Review.

PMID:
19716966
13.

Association of insomnia with quality of life, work productivity, and activity impairment.

Bolge SC, Doan JF, Kannan H, Baran RW.

Qual Life Res. 2009 May;18(4):415-22. doi: 10.1007/s11136-009-9462-6. Epub 2009 Mar 14.

PMID:
19288223
14.

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. Epub 2007 Oct 4.

PMID:
17916806
15.

Activity limitation and quality of life in COPD.

Jones PW.

COPD. 2007 Sep;4(3):273-8. Review.

PMID:
17729072
16.

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J; Global Initiative for Chronic Obstructive Lung Disease.

Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. Epub 2007 May 16. Review.

PMID:
17507545
17.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.

PMID:
17310045
18.

A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease.

Darkow T, Kadlubek PJ, Shah H, Phillips AL, Marton JP.

J Occup Environ Med. 2007 Jan;49(1):22-30.

PMID:
17215710
19.

Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?

Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU.

Chest. 2006 Oct;130(4):1117-28.

PMID:
17035446
20.

Health-related quality of life is related to COPD disease severity.

Ståhl E, Lindberg A, Jansson SA, Rönmark E, Svensson K, Andersson F, Löfdahl CG, Lundbäck B.

Health Qual Life Outcomes. 2005 Sep 9;3:56.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk